Key Finding
Research on T cells and myasthenia gravis has increased significantly over the past decade, with emerging therapeutic directions including CAR-T cell therapy and extracellular vesicle-based drug delivery showing promise for personalized treatment approaches.
Myasthenia gravis (MG) is a serious autoimmune condition that causes muscle weakness and fatigue. Researchers conducted a comprehensive review of global scientific studies examining the relationship between T cells (immune system cells) and myasthenia gravis. They analyzed research publications from major databases to understand trends, research hotspots, and emerging treatment directions. The study found that interest in T cell research for MG has grown significantly over the past decade. T cells play a critical role in regulating the immune response that produces the antibodies causing MG symptoms. The researchers identified several promising research areas, including new immunotherapy approaches, CAR-T cell therapy (a type of treatment that reprograms immune cells), and innovative drug delivery methods using extracellular vesicles. These emerging treatments could potentially offer more personalized and effective options for managing MG in the future. While this study focused on conventional medical research and immunotherapy, patients with autoimmune conditions like MG often seek complementary approaches to support their overall health and manage symptoms. Some patients explore acupuncture as part of an integrative approach to address fatigue, muscle weakness, and stress associated with chronic autoimmune conditions. The review emphasizes that bridging the gap between laboratory research and clinical practice remains essential for developing better treatments. If you're considering acupuncture as a complementary therapy for myasthenia gravis, consult with a licensed acupuncturist experienced in treating autoimmune conditions and coordinate care with your neurologist.
This bibliometric analysis examined the research landscape of T cells in myasthenia gravis (MG) using Web of Science Core Collection and PubMed databases. The authors employed CiteSpace and VOSviewer visualization tools to analyze temporal trends, research collaborations, influential publications, and keyword evolution. The analysis revealed substantial growth in T cell-related MG research over the past decade. Key research areas identified include T cell and B cell subset roles, cytokine involvement, immune checkpoint inhibitor-associated MG (ICI-MG), and novel immunotherapies. Emerging frontiers include CAR-T cell therapy and extracellular vesicle-based drug delivery systems. The study provides no clinical trial data or effect sizes, as it is a literature review rather than an interventional study. Clinical takeaway: Understanding T cell mechanisms in MG pathophysiology may inform future integrative approaches, though current evidence for acupuncture in autoimmune neuromuscular disorders remains limited and warrants further investigation.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Dysregulation of m7G RNA modifications, catalyzed by three major methyltransferase complexes in the CNS, is associated with the pathogenesis of multiple neurological diseases including Alzheimer's disease, ALS, epilepsy, glioblastoma, and ischemic stroke.
📌 Acupuncture significantly reduced thyroid antibodies (TPOAb and TGAb) and TSH levels in Hashimoto thyroiditis patients, though methodological limitations prevent reliable clinical recommendations pending higher-quality research.
📌 Liproxstatin-1 significantly reduced cerebral ischemia-reperfusion injury in rats by inhibiting ferroptosis through increasing neuroprotective factors GPX4 and FTH1 while decreasing ferroptosis markers NOX1, ACSL4, COX2, and TFR1.